-
Nanox Announces $15 Million Registered Direct Offering of Common Stock
24 Nov 2025 04:26 GMT
… LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging … sale of 3,826,530 ordinary shares (“Common Stock”) in a registered direct offering … Nano-X Imaging Ltd. Nanox (NASDAQ: NNOX) is focused on driving …
-
LaFayette Acquisition Corp. Announces the Separate Trading of Its Ordinary Shares and Rights, ...
21 Nov 2025 23:02 GMT
… to separately trade the ordinary shares and rights included in … the units.
The ordinary shares and rights that are … to trade on the Nasdaq Global Market (“Nasdaq”) under the symbols … to separate the units into ordinary shares and rights.
×
Javascript is …
-
LaFayette Acquisition Corp. Announces the Separate Trading of Its Ordinary Shares and Rights, Commencing on or About November 26, 2025
21 Nov 2025 21:30 GMT
… to separately trade the ordinary shares and rights included in … the units. The ordinary shares and rights that are … to trade on the Nasdaq Global Market (“Nasdaq”) under the symbols … to separate the units into ordinary shares and rights. A registration …
-
Pyxis Tankers Announces New $3 Million Common Share Re-purchase Program
21 Nov 2025 13:30 GMT
… – Pyxis Tankers Inc. (the “Company”) (NASDAQ Cap Mkts: PXS), (the “Company … $3.0 million of our common shares. We believe our current share …
-
Webull Corporation Class A Ordinary Shares (NASDAQ:BULL) Q3 2025 Earnings Call Transcript
21 Nov 2025 13:10 GMT
… Ordinary Shares (NASDAQ:BULL) Follow Webull Corporation Class A Ordinary Shares (NASDAQ:BULL … Ordinary Shares or discovering Webull Corporation Class A Ordinary Shares … Ordinary Shares (NASDAQ:BULL) Follow Webull Corporation Class A Ordinary Shares (NASDAQ: …
-
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and ...
21 Nov 2025 03:57 GMT
… NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company … 779 shares of common stock. The shares of common stock are being … offering price for the common stock less the $0.001 … ,827 shares of its common stock at the public offering …
-
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
21 Nov 2025 02:54 GMT
… NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company … 779 shares of common stock. The shares of common stock are being … offering price for the common stock less the $0.001 … ,827 shares of its common stock at the public offering …
-
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
20 Nov 2025 21:12 GMT
… ) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company … of its common stock and, in lieu of common stock to certain … purchase shares of its common stock. In addition, Inhibikase … number of shares of common stock Inhibikase is offering, at …
-
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
20 Nov 2025 21:01 GMT
… , Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical … ,500,000 shares of its common stock, which includes the full exercise … ,500,000 additional shares of common stock, at a price to the …
-
Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
22 Nov 2025 14:58 GMT
… of Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP) resulting from allegations … news, Zions Bancorporation, N.A. common stock fell 13.14% on October …
About
© 1995-2025